Therapeutic Advances in Endocrinology and Metabolism

Papers
(The TQCC of Therapeutic Advances in Endocrinology and Metabolism is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Effect of sodium-glucose cotransporter-2 inhibitors on patients with essential hypertension and pre-hypertension: a meta-analysis134
In-person and virtual multidisciplinary intensive lifestyle interventions are equally effective in patients with type 2 diabetes and obesity121
Treatment of osteoporosis in the solid organ transplant recipient: an organ-based approach63
The global burden of thyroid cancer in high-income Asia-Pacific: a systematic analysis of the Global Burden of Disease study40
Role of epicardial adipose tissue in diabetic cardiomyopathy through the lens of cardiovascular magnetic resonance imaging – a narrative review37
Controversies in the management of active Charcot neuroarthropathy31
Gender-affirming hormone therapy, mental health, and surgical considerations for aging transgender and gender diverse adults31
Insulin therapy among diabetic patients in rural communities of Sub-Saharan Africa: a perspective review27
Glycaemic outcomes in people living with diabetes under 65 and over 65 years old using an intermittently scanned continuous glucose monitoring system22
Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease22
Novel therapeutic targets for metabolism-related diseases: proteomic Mendelian randomization and colocalization analyses21
Update on genetics and epigenetics in metabolic associated fatty liver disease21
Differences in adherence to using removable cast walker treatment during daytime and nighttime weight-bearing activities in people with diabetes-related foot ulcers21
Effectiveness of open-source Android artificial pancreas systems for glucose management in patients with type 1 diabetes: a real-world study21
Chronic kidney disease combined with metabolic syndrome is a non-negligible risk factor20
Pheochromocytoma: a changing perspective and current concepts19
Is there a causal relationship between hypothyroidism and hyponatremia?18
Prevalence and associated factors of hyperuricemia among Chinese patients with diabetes: a cross-sectional study17
Design and rationale for the SIB trial: a randomized parallel comparison of semaglutide versus placebo on intestinal barrier function in type 2 diabetes mellitus17
Using digital tools to improve diabetes care in India with continuous glucose monitoring17
Diagnostic performance of morning basal serum cortisol for assessing adrenal reserve: a single-center experience from the United Arab Emirates17
A study looking at how missed somatropin injections affect growth in children with growth hormone deficiency: a plain language summary of publication16
Risk factor management over two decades in hospitalised patients with chronic limb-threatening ischaemia with and without diabetes mellitus16
The legacy effect of early HbA1c control on microvascular complications and hospital admissions in type 2 diabetes: findings from a large UK study16
Retraction notice15
Limitation of the current Lin-Weiss-Bisceglia criteria in predicting poor prognosis in oncocytic adrenocortical neoplasms of uncertain malignant potential and oncocytoma diagnosed by the Lin-Weiss-Bis15
Role of estrogen in the regulation of central and peripheral energy homeostasis: from a menopausal perspective15
Bone health in transgender people: a narrative review14
Exploring the weight bias of professionals working in the field of obesity with a mobile IAT: a pilot study14
Immune cell infiltration in the pancreas of type 1, type 2 and type 3c diabetes14
Management strategies for patients with insulin allergy at risk of acute complications: experience from a case report14
The role of supporting and disruptive mechanisms of FT3 homeostasis in regulating the hypothalamic–pituitary–thyroid axis13
The missing piece in post-transplant bone health: tertiary hyperparathyroidism management13
Influence of the occurrence and duration of partial remission on short-term metabolic control in type 1 diabetes: the DIABHONEY pediatric study13
Temporal patterns of inpatient hypoglycaemia are treatment-dependent13
Gender-affirming endocrine care for youth with a nonbinary gender identity12
Thanks to Reviewers11
Efficacy and safety of tirzepatide in subjects with type 2 diabetes and chronic kidney disease: a prospective, two-arm observational study11
Therapeutic potential of adiponectin in prediabetes: strategies, challenges, and future directions11
The impact of socioeconomic factors, social determinants, and ethnicity on the utilization of glucose sensor technology among persons with diabetes mellitus: a narrative review11
Timing of osteoporosis therapies following fracture: the current status11
Potential of duodenal mucosal resurfacing in achieving glycemic control in Asians with type 2 diabetes11
Glycogen storage disease type III: a mixed-methods study to assess the burden of disease10
Comparing quality of life in traditional face-to-face visits with a hybrid approach of telemedicine with in-person follow-ups in recent users of advanced closed-loop systems: a randomized controlled c10
Analysis of vitamin D nutritional status and disease risk factors in patients with subacute thyroiditis10
The bidirectional impacts of alcohol consumption and MAFLD for progressive fatty liver disease10
0.21549105644226